AUG 03, 2020 6:43 AM PDT

Understanding How Disease Risk Begins in Development

WRITTEN BY: Carmen Leitch

Many common complex diseases are thought to be caused by an interplay of genetic and environmental factors. Researchers have been trying to learn more about the small genetic changes that people carry that predispose them to certain diseases. Knowing who is at greater risk could help them modify their environment or behavior to reduce their likelihood of developing a complex disorder, whether it be heart disease or rheumatoid arthritis. Many studies that have looked at genetic variants that predispose people to disease, however, have focused on genetic material obtained from adults. New research has examined these variations in neonates.

Image credit: Public domain files

Reporting in Nature Communications, scientists identified several places in the human genomes that may be affecting a person's risk of chronic immune and inflammatory diseases, which may have roots in early childhood. This work utilized DNA and immune cells harvested from 100 cord blood samples from newborn Australians enrolled in the Childhood Asthma Study, aimed to learn more about the genetic variation in places that code for portions of the immune system.

The researchers exposed the immune cells to certain stimuli, then examined the genetic variation in the cells that may have led to differences in their responses.

"We looked for overlap between these genetic signals and those that are known to be associated with diseases where we know the immune system plays a role," explained Dr. Michael Inouye, Munz Chair of Cardiovascular Prediction and Prevention at the Baker Institute and Principal Researcher at Cambridge University. "We then used statistical analysis to search for possible links between the cell response in newborns and immune diseases in adulthood."

Thousands of genetic variants were identified, with various effects. "Our study showed the potential roles of gene expression in disease development, which has helped us to better understand the link between DNA variation and disease risk," said Dr. Qinqin Huang, lead author of the study and now a researcher at the Wellcome Sanger Institute in Cambridge.

"To date, similar studies have only been conducted in adult immune cells. Given the huge difference between neonatal and adult immunity, it is not surprising to see many signals that were unique to newborns."

"Disease is partly due to changes, both large and small, in our genome - the DNA that we're born with and which is a major driving force in all our cells. That means, genomics can be used to estimate disease risk from a very early age," Dr. Inouye said.

"Common diseases, such as type 2 diabetes and cardiovascular disease, tend to be polygenic - influenced by a large number of genetic variants scattered throughout the genome, which combine with environmental and lifestyle factors. By using new genomic technology and supercomputing capabilities, we can sift through this DNA data and piece together the puzzles that underlie each disease.

"With so many diseases sharing a root in the immune system and inflammation we can leverage this information to better understand where each disease has a molecular weak spot and to what extent these are shared among different diseases. We've shown this can be dissected using genetics and polygenic risk, hopefully leading to targeted preventative interventions for those who need them most, with the aim of keeping people living healthier for longer."

Sources: AAAS/Eurekalert! via Baker Heart and Diabetes Institute, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
NOV 08, 2020
Genetics & Genomics
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
NOV 08, 2020
Drug-Resistant Microbes Persist in Hospitals After Deep Cleaning
Researchers have found that drug-resistant bacteria can hang around even after deep cleaning. They used genome sequencin ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
NOV 14, 2020
Cannabis Sciences
New Genetic Test Identifies Cannabis THC Levels from Seeds
NOV 14, 2020
New Genetic Test Identifies Cannabis THC Levels from Seeds
Researchers from the University of Minnesota have developed a genetic test that can predict how much cannabidiol (CBD) o ...
DEC 24, 2020
Genetics & Genomics
After Chromosomes Shatter, Cancer Cells Can Become Drug-Resistant
DEC 24, 2020
After Chromosomes Shatter, Cancer Cells Can Become Drug-Resistant
Many types of cells have to be replenished throughout our lives, and cells divide to replace those that are damaged or w ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
Loading Comments...